StonvexLoading…
StonvexStonvexStonvexCore line items from ULS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.05B | $2.87B | $2.68B | $2.52B |
Operating Income | $522.00M | $462.00M | $368.00M | $412.00M |
Net Income | $325.00M | $326.00M | $260.00M | $293.00M |
EPS (Diluted) | $1.60 | $1.62 | $1.30 | $1.47 |
Total Assets | $2.92B | $2.80B | $2.74B | Not available |
Total Liabilities | $1.63B | $1.87B | $2.06B | Not available |
Cash & Equivalents | $295.00M | $298.00M | $315.00M | $322.00M |
Free Cash Flow OCF − CapEx | $403.00M | $287.00M | $252.00M | $208.00M |
Shares Outstanding | 201.03M | 200.17M | 200.00M | 200.00M |